PKTX.US Protokinetix Inc

Healthcare Biotechnology USA Stocks
0.0020 USD
Close of Nov 11, 2026
0.0001 0.0124
Market cap
USD 824K
P/E
-
P/B
3.33x
ROE
-148.6%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is PKTX.US undervalued?

Graham number

The Graham number of Protokinetix Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Protokinetix Inc fundamental analysis

No fundamental analysis for Protokinetix Inc yet.

Protokinetix Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Protokinetix Inc

ProtoKinetix, Incorporated, a research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs). Its AFGPs are used in various commercial applications, such as targeted health care solutions, as well as AAGPs are used in ophthalmology, dermatology, transplants, and biomanufacturing areas. The company was formerly known as RJV Network, Inc. and changed its name to ProtoKin…

Full company profile